• Home
  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Cardiology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma News
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Subscribe
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
Skip to content
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma News

BioPharma News

Biopharmaceutical industry analysis. Credible, reliable, equitable.

Subscribe
  • Home
  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Cardiology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma News
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Subscribe

Regulatory

Actions of government agencies regulating the pharmaceutical industry: approval, rejection, and prohibition of drugs, granting special statuses.

Paxlovid (nirmatrelvir + ritonavir).
Posted inCOVID-19, Infections, New Drugs, Regulatory

Paxlovid Approved in the U.S.

by Tanya von Reuss December 22, 2021September 8, 2022

Pfizer’s oral antiviral drug has entered the world’s main pharmaceutical market.

Posted inInfections, New Drugs, Regulatory

Apretude: New Drug to Prevent HIV Infection

by Julia Mardi December 21, 2021September 8, 2022

Injecting cabotegravir once every two months will high effectively protect against HIV infection.

asthma
Posted inAutoimmune Diseases, New Drugs, Regulatory

Tezspire: Effective Treatment for Severe Uncontrolled Asthma

by Mark Gubar December 19, 2021September 8, 2022

Tezepelumab is a powerful new drug for asthma, invented by Amgen and AstraZeneca, with a completely new mechanism of action.

Posted inAutoimmune Diseases, New Drugs, Rare/Orphan Diseases, Regulatory

Vyvgart: New Drug to Treat Myasthenia Gravis

by Tanya von Reuss December 19, 2021September 8, 2022

Efgartigimod developed by Argenx is a strong competitor to Soliris.

Posted inInfections, New Drugs, Regulatory

Fetroja/Fetcroja: New Cephalosporin That Bypasses All Antibiotic Resistance

by Nik Resovski December 11, 2021September 8, 2022

The antibiotic Fetroja/Fetcroja penetrates bacteria like a Trojan horse.

Posted inInfections, New Drugs, Regulatory

Aklief, Amzeeq, Winlevi: Newest Drugs for Acne Vulgaris Treatment

by Julia Mardi and Mark Gubar December 11, 2021November 5, 2022

Trifarotene, minocycline, and clascoterone are new effective drugs for the topical treatment of acne in children and adults.

Posted inNew Drugs, Rare/Orphan Diseases, Regulatory

Trikafta/Kaftrio: World’s First Triple Therapy for Cystic Fibrosis

by Mark Gubar and Julia Mardi December 9, 2021September 8, 2022

The combination drug will help almost all cystic fibrosis patients.

Posts pagination

Newer posts 1 … 7 8 9 10 11 … 14 Older posts
BioPharma News Logo
Biopharmaceutical industry analysis.
© 2025 BioPharma News Powered by Newspack Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma News

Awareness and enlightenment are strengths.

BioPharma News is an amazing and trustworthy non-profit data analysis service that provides honest and objective reporting on the Pharma & Biotech industry. We would like to invite you to sign up for our weekly Newsletter to stay informed and uptodate.

Please check your inbox or spam folder for an email from [email protected] to confirm your subscription.

×